TipRanks
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market
Want to see JP:4528 full AI Analyst Report?

ONO Pharmaceutical Co (4528) Drug Pipeline

1 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Ono-4915
Sjogren's Disease
Phase II
Not Yet Recruiting
ONO-4915 in Patients With Primary Sjogren's Disease
Sep 03, 2026
Ono-7429
Solid Tumors
Phase I
Recruiting
A Study of ONO-7429 in Participants With Unresectable Advanced or Recurrent Solid Tumors
Aug 18, 2026
Ono-6414
Ulcerative Colitis (Uc)
Phase I
Recruiting
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
Jul 31, 2026
Ono-4538Hsc
Pediatric Malignant Solid Tumor And Epithelioid Sarcoma
Phase I/II
Recruiting
A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
Jul 06, 2026
Dcc-2618
Gastrointestinal Stromal Tumors
Phase I
Recruiting
Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
May 25, 2026
Cenobamate For 12 To < 18 Year Olds, Cenobamate For 2 To < 18 Year Olds
Partial Epilepsy
Phase III
Recruiting
A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
May 11, 2026
―
Sapablursen
Polycythemia Vera
Phase III
Recruiting
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Feb 18, 2026
Tirabrutinib
Primary Central Nervous System Lymphoma (Pcnsl)
Phase I
Completed
A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants
Aug 31, 2025
Rituximab, Temozolomide, Tirabrutinib
Relapsed/Refractory Primary Central Nervous System Lymphoma
Phase III
Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Jul 29, 2025
Bevacizumab, Oxaliplatin, Leucovorin, 5-Fluorouracil, Ono-4578, Opdivo
Colorectal Cancer
Phase II
Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Apr 21, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does ONO Pharmaceutical Co Ltd (4528) have in its pipeline
      4528 is currently developing the following drugs: Ono-4915, Ono-7429, Ono-6414. These drug candidates are in various stages of clinical development as the company works toward FDA approval.